First Human Trial of Paradromics Brain Implant a Success

Paradromics' Brain Implant Shows Promise in First Human Trial A groundbreaking medical advancement has been reported by the American company Paradromics. Their brain-computer interface, Connexus, was successfully tested on a human for the first time. The procedure, performed at the University of Michigan, involved implanting and removing the device in under 20 minutes. The trial successfully recorded brain signals, a major step toward helping those with severe motor disabilities. "In less than 20 minutes, the Connexus chip was implanted and removed from the brain of a patient," Paradromics announced in a statement. The company emphasizes that the test used techniques familiar to neurosurgeons, minimizing risks. The implant was placed in the temporal lobe, the brain area responsible for memory and hearing. Paradromics' technology utilizes artificial intelligence to interpret brain signals, potentially enabling patients to communicate through machines, write, or control a computer cursor. Their ultimate goal is to restore communication for those suffering from ALS, stroke, or spinal cord injuries. This technology is similar to Elon Musk's Neuralink, but with a different configuration, using 420 micro-needles as electrodes. The company plans a clinical trial to evaluate the long-term safety and efficacy of Connexus. While still awaiting regulatory approval, this successful initial trial represents a significant leap forward in brain-computer interface technology, offering hope to millions affected by debilitating motor impairments.